Date of Conferral
2022
Degree
Doctor of Business Administration (D.B.A.)
School
Business Administration
Advisor
Edward Paluch
Abstract
Some pharmaceutical brand protection managers lack strategies to mitigate financial losses from counterfeit prescription drugs. A multilayered approach involving guiding principles, supply chain security, investigations, enforcement, advocacy, and awareness can help mitigate potential financial losses and keep patients safe. Guided by the Six Sigma define, measure, analyze, improve, and control (DMAIC) model and the fraud triangle conceptual framework, the purpose of this multiple case study was to explore strategies brand protection managers use to mitigate financial losses from counterfeit prescription drugs. Data collection included three semi-structured interviews using Zoom. Analyzing data entailed transcribing and coding themes within data and relating findings to the composite conceptual framework and peer-reviewed literature. Four key themes emerged: (a) guiding principles, (b) securing the supply chain, (c) investigations and enforcement, and (d) advocacy and awareness. The primary recommendation for pharmaceutical brand managers is to build a risk profile for each product based on knowledge of how counterfeiters behave and implement a multilayered approach for improved supply chain security while educating consumers on risks associated with purchasing medications outside the legitimate supply chain. The implications for positive social change include the possibility to inform more consumers on potential risks, which could save lives.
Recommended Citation
Blais, Denise, "Strategies for Preventing and Mitigating Counterfeit Medication From Entering the U.S. Supply Chain" (2022). Walden Dissertations and Doctoral Studies. 13210.
https://scholarworks.waldenu.edu/dissertations/13210
